Science
Mechanism of Action
This ingredient functions as a robust antioxidant, actively neutralizing free radicals and reactive oxygen species induced by environmental stressors like UV radiation and pollution, thereby protecting cellular components and inhibiting lipid peroxidation. It exhibits significant anti-glycation properties by targeting glycation reactions in structural proteins to preserve collagen elasticity and reducing the formation of Advanced Glycation End-products (AGEs), which helps to maintain skin resilience and reduce the appearance of wrinkles. Additionally, Decarboxy Carnosine HCl displays anti-inflammatory effects by reducing the production of pro-inflammatory cytokines (e.g., TNF-α, IL-8), which helps to soothe irritated skin and alleviate redness. Furthermore, it contributes to photoprotection by neutralizing free radicals from UV exposure and shielding DNA from UV-B radiation damage, supporting skin barrier integrity, brightening, and enhancing firmness and elasticity.
Research
Clinical Evidence
Low confidence0.1%
Key findings
- 01 Usage rates of 0.1-0.2% are cited for anti-aging products, where it is believed to contribute to facial brightness, lifting, and tightening of the skin over 8 consecutive weeks. However, this is a reported usage rate and not derived from a specific peer-reviewed clinical study on topical application.
- 02 An oral supplementation study of 300 mg/day (Glycoxil®) for 90 days in participants aged 30-50 with mature skin showed slight improvements in rhytids via Focco® equipment analysis in the treatment group between baseline and day 90, although no objective statistical differences were observed between treatment and placebo groups. Blinded dermatologists, however, noted subjective improvements in hydration, firmness, and texture in both groups.
Transparency
Dusting Analysis
While industry usage rates for perceived benefits are cited between 0.1-0.2% in anti-aging products, regulatory guidance from the Australian Industrial Chemicals Introduction Scheme (AICIS) recommends a maximum concentration of 0.05% for dermal cosmetic products. This disparity indicates a potential for product formulations to exceed the recommended safety threshold in pursuit of marketing claims, suggesting a 'dusting' scenario where efficacy claims might outpace safe concentration limits.
The Formula
Formulation
Stability
To maintain optimal performance, avoid temperatures exceeding 40°C. The ingredient is compatible with common cosmetic excipients, including humectants, emulsifiers, and gelling agents, ensuring stable integration into aqueous and emulsion systems. For maximum shelf life, refrigeration at 5-10°C, away from light and air, is recommended for at least 24 months.
Safety
Safety Profile
Decarboxy Carnosine HCl has not been specifically reviewed by the Cosmetic Ingredient Review (CIR) Expert Panel. The Australian Industrial Chemicals Introduction Scheme (AICIS) advises a maximum concentration of 0.05% for dermal cosmetic products and explicitly states it should not be used in topical products intended for the eye area. The European Chemicals Agency (ECHA) GHS classification for the raw material indicates it 'Causes skin irritation' (H315) and 'Causes serious eye damage' (H318). However, EWG Skin Deep rates it 'LOW' for common concerns including allergies, immunotoxicity, and developmental toxicity, consistent with Incidecoder's 'low' irritancy rating for formulated cosmetic products.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Decarboxy Carnosine HCl is a valuable multi-functional ingredient offering significant antioxidant, anti-glycation, and anti-inflammatory benefits for comprehensive skin health, though its optimal topical concentration for efficacy should carefully align with regulatory safety recommendations, particularly regarding the 0.05% maximum for dermal products and avoidance in eye-area applications.
Related
Similar Ingredients
Finding similar ingredients…